Quris AI

🚀 Revolutionising Drug Discovery with AI and Patient-on-Chip Technology! 🧬 Excited to share Pharma IQ's latest article on how AI and patient-on-chip technology are transforming drug discovery and development. Discover how these advancements are not only improving safety predictions but also paving the way for personalised medicine. 💡 As Isaac Bentwich from Quris AI explained in our interview with him: "Creating miniaturised versions of the human organs on microfluidic chips allows for more accurate simulations of human physiology, providing better predictions of drug interactions." Read the full article here: https://bit.ly/4fRvFPx Additionally, check out our comprehensive guide on Maximising ROI from Drug Discovery: https://bit.ly/3WgVteI 🔗 Don’t miss our upcoming event AI for Pharma & Healthcare, happening from 24-26 September in Amsterdam. Join us to explore the latest innovations and network with industry leaders. Register here: https://bit.ly/3W9SEvP Isaac Bentwich Quris AI Danielle Dougan #AIDrugDiscovery #PatientOnChip #PersonalizedMedicine #PharmaInnovation #HealthcareAI #DrugDevelopment #Biotech #Pharma

Pharma Focus Asia Magazine's Issue #55 explores the transformative impact of AI on the pharmaceutical industry. Our CEO, Dr. Isaac Bentwich, has contributed an article to this issue, addressing the $53 billion challenge pharmaceutical companies face and how AI and ‘patient-on-a-chip’ technology offer solutions. Read more- https://lnkd.in/gAAbc_e #QurisAI #AIinHealthcare #pharma #biotech 

🌟 Exciting Feature Alert! 🌟 We’re thrilled to share a recent feature in In Vivo, discussing Quris AI's pioneering efforts in leveraging AI to eliminate the need for animal testing in drug trials. Join us as we lead the way toward a future where drug development is faster, safer, cheaper, and more humane. #QurisAI #DrugSafety #ArtificialIntelligence #InnovationInPharma #AnimalFreeTesting Read the full article here: https://lnkd.in/dQ5TWjcx

This past week, our CEO, Isaac Bentwich, delivered an insightful presentation at the Biomed Conference. He shared groundbreaking developments in Bio-AI technology and how Quris-AI is at the forefront of enhancing drug safety prediction. Thank you to everyone who attended and engaged with us. Your enthusiasm and questions enriched the discussion and highlighted the critical role of innovation in healthcare. #BiomedConference #InnovationInHealthcare #DrugSafety #BioAI #QurisAI

The FDA's ongoing efforts to shape AI's role in drug development mark a significant advancement for the industry. With new guidelines and discussion papers, the FDA is paving the way for innovative solutions to enhance drug safety and efficacy evaluations. Quris AI’s platform utilizes advanced AI to better predict which drug candidates will safely work in humans, avoiding the tremendous costs of failed clinical trials. This approach not only aligns with the FDA’s emphasis on robust data quality and continuous real-world performance monitoring but also addresses the critical need for more accurate pre-clinical predictions. Stay informed about these regulatory changes and explore how Quris AI is leveraging cutting-edge technology to transform drug development. Read more: https://lnkd.in/gpdXHdZ #RegulatoryUpdate #FDA #AIinHealthcare #QurisAI

AI continues to unlock unprecedented possibilities in drug testing and development. A recent article from BioPharmaTrend.com highlights AI's transformative journey in drug discovery, showcasing groundbreaking concepts that have reshaped and continue to reshape traditional approaches. Quris AI is proud to be a part of this revolution, with our Bio-AI Clinical Prediction Platform that is revolutionizing how drug candidates are evaluated for safety and efficacy in humans. Together, we will continue driving innovation and transforming healthcare. https://lnkd.in/eTwDwMgn  #AI #DrugDiscovery #HealthcareInnovation #QurisAI

Quris-AI is thrilled to join the AstraZeneca BioVentureHub in Gothenburg! Our journey forward includes assembling a dynamic team at this cutting-edge site, and harnessing exceptional R&D insights and resources like never before! Cheers to growth, innovation, and transforming drug development, together. #BioVentureHub #Innovation #Collaboration

💡 Quris AI's groundbreaking approach combines artificial intelligence with patients-on-chip technology, offering a new horizon in pharmaceutical research. Their Bio-AI Clinical Prediction Platform is setting new benchmarks in predicting drug safety, significantly reducing the risk and cost associated with clinical trials. Discover the future of pharmaceuticals with Quris on this episode of #InsideTheBlueprint: https://bit.ly/3sQ8gKB #PharmaceuticalInnovation #AIDrugDevelopment #QurisAI #PharmaIndustry #HealthcareIndustry

Thrilled to announce Quris-AI's participation in the 23rd Annual Bio-IT World Conference & Expo in Boston this April! Our CEO, Isaac Bentwich, will be among the distinguished speakers, sharing insights on leveraging #AI in #DrugDiscovery and development. #BioITWorld #PrecisionMedicine #QurisAI

We're thrilled to share an insightful interview with our CEO, Isaac Bentwich, where he delves into the groundbreaking work we're doing at Quris-AI. Recently honored as one of the World's Most Innovative Companies by Fast Company, our patented organ-on-chip system combined  with AI is setting new standards in predicting drug trial outcomes. 🌐 Read the full interview to discover more: https://lnkd.in/dBira-8g